Your browser doesn't support javascript.
loading
Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells.
Meurer, Steffen K; Tezcan, Okan; Lammers, Twan; Weiskirchen, Ralf.
Afiliación
  • Meurer SK; Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany. Electronic address: smeurer@ukaachen.de.
  • Tezcan O; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, D-52074 Aachen, Germany.
  • Lammers T; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, Faculty of Medicine, RWTH Aachen University, D-52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical
  • Weiskirchen R; Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany. Electronic address: rweiskirchen@ukaachen.de.
Cell Signal ; 74: 109731, 2020 10.
Article en En | MEDLINE | ID: mdl-32758668
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína Morfogenética Ósea 2 / Neoplasias de la Mama Triple Negativas / Lipocalina 2 Límite: Animals / Female / Humans Idioma: En Revista: Cell Signal Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína Morfogenética Ósea 2 / Neoplasias de la Mama Triple Negativas / Lipocalina 2 Límite: Animals / Female / Humans Idioma: En Revista: Cell Signal Año: 2020 Tipo del documento: Article